Literature DB >> 11800088

Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes.

H Goto1, H Matsuo, S Nakane, H Izumoto, T Fukudome, C Kambara, N Shibuya.   

Abstract

Plasmapheresis not only removes humoral factors, but may also modulate cellular immunity. We investigated whether plasmapheresis influenced T helper type-1/T helper type-2 (Th1/Th2) cytokine-producing-cell balance in 3 patients with neuroimmunological disease. The production of interferon-gamma (IFN-gamma), interleukin-2 (IL-2), and IL-4 in the culture supernatant of peripheral blood mononuclear cells stimulated by anti-CD3 and anti-CD28 was assayed. In 2 of 3 patients, plasmapheresis (immunoadsorption or plasma exchange) reduced Th1/Th2 cytokine ratio. The results may suggest that plasmapheresis induces a shift of Th1/Th2 balance in peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800088     DOI: 10.1046/j.1526-0968.2001.00386.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  15 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Can plasma exchange therapy induce regulatory T lymphocytes in multiple sclerosis patients?

Authors:  A Jamshidian; M Gharagozloo
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

3.  Stabilization Without Rituximab After Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature Overview.

Authors:  Chantal Kahovec; Michael C Levin
Journal:  Int J MS Care       Date:  2019 May-Jun

4.  Neuromyelitis optica.

Authors:  William M Carroll; Kazuo Fujihara
Journal:  Curr Treat Options Neurol       Date:  2010-05       Impact factor: 3.598

Review 5.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

6.  Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome.

Authors:  Anush Martirosyan; Martin Petrek; Amit Kishore; Gayane Manukyan
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

7.  Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses.

Authors:  Simon Faissner; Johanna Nikolayczik; Andrew Chan; Kerstin Hellwig; Ralf Gold; Min-Suk Yoon; Aiden Haghikia
Journal:  J Neurol       Date:  2016-04-02       Impact factor: 4.849

8.  Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Eduardo Adonias De Sousa; Thomas H Brannagan
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

9.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22

10.  Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis.

Authors:  Andreas Rogalewski; Jörg Kraus; Martin Hasselblatt; Christoffer Kraemer; Wolf-Rüdiger Schäbitz
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.